GHOSH ANIRVAN (Chief Executive Officer) sold 1.4% of their position (1.18K shares) of UNITY BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $3.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/27/2023ACC: 0000950170-23-030189
DirectorOfficer· Chief Executive Officer
Since Mar 2020
-1.18K
Net shares
Net seller
$3.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.18K disposed
Non-Derivative Transactions1
Common Stock, $0.0001 par value
Direct
Shares
−1.18K
Price / share
$3.20
Trade value
$3.77K
% of position
1.4%
6/26/2023
86.25K→85.07K
Total
Net shares
−1.18K
Net value
-$3.77K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value Direct | 6/26/2023 | S · Sale | −1.18K | $3.20 | $3.77K | 1.4% | 86.25K | 85.07K |
| Total | −1.18K | -$3.77K | ||||||
Derivative Transactions0
No derivative transactions reported